Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DTG/3TC vs BIC/FTC/TAF Maintenance Therapy in People Living with HIV
2024-515167-56-00Phase 4Completed
- Sponsor
- Fundación SEIMC-GeSIDA
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in human immunodeficiency virus infection (HIV) comparing Dovato arm with Biktarvy arm (2 arms). Primary endpoint: Virologic failure by FDA Snapshot. Started Sep 2024; status: completed.
02
Drugs
dolutegravir + lamivudinebictegravir + emtricitabine + tenofovir alafenamide
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2024-515167-56-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-515167-56-00.